Subscribe for great stories in your community!
Recently Hatfield-based Code Biotherapeutics raised $75 million to develop genetic medicines that are based on technology aimed at increasing the applicability of these types…
Hatfield-based Code Biotherapeutics has entered into a collaboration and option deal with Takeda with a potential value of $2 billion, writes John George for…
Before we send you to this site, please subscribe to our daily newsletter.